A new study reveals that the world’s most widely used diabetes drug works through a previously unknown brain pathway ...

The most recent version of NG28, the National Institute for Health and Care Excellence's (NICE) guidelines for managing type 2 diabetes in adults, has been released on February 18, 2026.

Sustained GLP-1 receptor agonist therapy is linked to greater improvements in A1c levels than DPP-4 inhibitor therapy in patients with type 2 diabetes, a Danish real-world analysis shows.

The nonsteroidal mineralocorticoid receptor antagonist finerenone has been reported to improve kidney and cardiovascular outcomes in persons with type 2 diabetes and chronic kidney disease (CKD).

A recent study has found that 7 hours and 18 minutes may be the optimal amount of sleep you need each night to lower your ...

Chinese scientists have achieved the world's first reversal of type-2 diabetes using stem-cell therapy. Here is what you need ...

Jardiance (empagliflozin) is a medicine for type 2 diabetes approved by the FDA in 2014. It is approved to help lower blood sugar levels in adults and children with type 2 diabetes and to lower the ...

Certain dietary supplements may help you manage complications or improve your blood sugar numbers, but the research is often inconclusive. Note: The U.S. Food and Drug Administration (FDA) does not ...

A recent study has found that eating higher levels of red meat is associated with an increased risk of developing type 2 ...

Children whose mothers had diabetes during pregnancy had a higher risk for developing epilepsy during childhood, according to a study published in Pediatrics.“Our findings highlight that prenatal ...